DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Mass Spectrometry: Americas Markets, Developments and Opportunities 2017 - 2020" report to their offering.
This study, which estimates a current 'MS analysis' global market size of $6.8 billion and growing to $9.2 billion (CAGR of 9%) over the next four years, profiles the use of mass spectrometry across more than 3,600 clinical and research organisations, encompassing 21 countries.
This study investigated growth in the use of mass spectrometry in terms of the number of mass spectrometry studies reported by end-users, which amounted to 11,600 studies over the period Jan 2013 to August 2016. A key goal in this study was to identify all major mass spectrometry laboratories globally, to allow estimates of market sizes in terms of sample throughput/analysis costs. Details of these organisations are provided as part of this report.
What This Report Offers
- Market Sizes ($Billions) : Across the Americas and the top-5 countries
- Market Growth (CAGR) : Across the Americas and the top-5 countries
- Opportunities: Gain access to core and developing opportunities in easiest-to-access market sectors
- Leading Market Sectors: Identify leading sectors in core and adjacent market areas
- Methods: Profile leading, growing and emerging methods and related methodologies and applications
- Applications: Identify leading, growing and emerging applications and related activities
- Reduce Risks and Costs: Reduce risks/costs by accurately profiling core and leading opportunities
- Targeted Marketing: Reach desired market groups by reliably profiling end-users market populations
- Increase Sales Opportunities: By identifying the most promising end-users in core market areas
- Emerging Markets: Identify 'small but rapidly growing' markets by accurate sector and segment profiling
- Increase ROI: Through reduced costs and increased sales, by accessing more qualified prospects and opportunities
Key Topics Covered:
Chapter 1. Introduction
Chapter 2. Americas Region
Chapter 3. Organisation Types, Americas
Chapter 4. Departments, Americas
Chapter 5. Clinical or Other, Americas
Chapter 6. MS System Configurations, Americas
Chapter 7. MS Applications, Americas
Chapter 8. Fragmentation Methods, Americas
Chapter 9. MS Ionisation, Americas
Chapter 10. Molecule Types, Americas
Chapter 11. Disease Areas, Americas
Chapter 12. Growth, Costs and Market Size
Chapter 13. Discussion
For more information about this report visit http://www.researchandmarkets.com/research/5fh2pt/mass